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Meprin A, the major matrix degrading enzyme in renal tubules,
produces a novel nidogen fragment in vitro and in vivo. We examined the
effect of meprin A, the major matrix degrading metalloproteinase in rat
kidney, on the laminin-nidogen complex. N-terminal sequence informa-
tion from the most abundant 55 kDa fragment revealed that it was a
breakdown product of nidogen rather than laminin. In comparison with
over 50 nidogen cleavage sites produced by other proteases, the meprin
A-induced nidogen cleavage site at amino acid position 899-900, a
glutamine-glycine site in the G3 domain, is unique. In addition, these data
demonstrate that meprin A degrades the G3 domain of nidogen even in
the presence of laminin binding, which usually accords protection from
proteolytic degradation. Meprin A also degraded purified nidogen into
similar breakdown products. Given that the tubular basement membrane
is located on the basilar side of the cell, the location of meprin A on the
apical brush border makes it difficult to envision a role for meprin A in
injury-induced basement membrane component breakdown. Thus, we
examined the possibility that following renal tubular epithelial cell injury,
meprin A undergoes a translocation to reach the underlying basement
membrane. After renal ischemia-reperfusion there was a marked alter-
ation in meprin A staining with meprin A now distributed throughout the
renal tubular cell cytoplasm and directly adherent to the tubular basement
membrane. This was in contrast to the usual linear staining of the brush
border of tubules in the corticomedullary junction. These data provide
unequivocal evidence that following injury, meprin A undergoes redistri-
bution and/or adherence to the tubular basement membrane. Since in our
in vitro studies, we identified a distinct meprin-induced 55 kDa nidogen
breakdown product, the urine was also examined for the presence of
nidogen degradation products after rat renal ischemia-reperfusion injury.
Western blots showed a marked increase in the urinary 55 kDa nidogen
fragment as early as the first day following ischemia-reperfusion injury and
continuing for six days. Taken together, these in vivo data strongly support
the notion that the nidogen breakdown products are the result of partial
degradation of tubular basement membrane by meprin A following renal
tubular ischemia-reperfusion injury.
Meprin A (EC.3.4.24.18) is a plasma membrane associated
metalloendopeptidase localized to the corticomedullary portion
of the proximal convoluted tubules in rat and mouse kidney [1].
Although meprin A had previously been shown to degrade various
proteins in vitro, including azocasein, insulin-B chain, parathyroid
hormone, its ability to degrade extracellular matrix components
was not known. We had observed the presence of a distinct
extracellular matrix degrading enzyme responsible for the vast
majority of extracellular matrix degradation in renal tubular cells
[2]. Unexpectedly, this renal tubular extracellular matrix degrad-
ing enzyme was identified and characterized as meprin A [3]. In a
previous study, we had also demonstrated marked alterations in
renal tubular laminin following ischemia-reperfusion injury to the
kidney [4]. The rapid and marked reduction in laminin present in
the renal tubular basement membrane is likely due to increased
degradation given that the turnover of basement membrane is
quite slow. Thus, in the present study we examined the ability of
meprin A to degrade the laminin-nidogen complex in vitro and to
identify the resulting breakdown products.
Meprin A is localized on the apical brush border opposite to the
basilar location of the tubular basement membrane. Hence, for
meprin A to play a role in basement membrane degradation in
vivo, it must undergo redistribution and/or adherence to the
underlying basement membrane. Therefore, we examined the
distribution of meprin A in rat kidney following ischemic acute
renal failure. Since in our in vitro studies, we identified a distinct
meprin induced nidogen breakdown product, we also examined
the urine for meprin A-induced laminin-nidogen degradation
products after rat renal ischemia-reperfusion injury.
METHODS
Materials
Gelatin Sepharose, concanavalin A-Sepharose, Sephadex
G-200, Sephacryl S-300, NP-40, soybean trypsin inhibitor, bovine
serum albumin, pepstatin, Triton X-100, molecular weight stan-
dards for gel filtration, leupeptin, pepstatin, and phenylmethylsul-
fonyl fluoride (PMSF) were obtained from Sigma Chemical Co
(St. Louis, MO, USA). Hydroxylapatite and all materials for gel
electrophoresis were obtained from Bio-Rad Labs (Richmond,
CA, USA). DEAE-cellulose (DE-52) was from Whatman Chem-
ical Separations, Ltd. (Hillsboro, OR, USA). Monoclonal anti-
bodies against Engelbreth Holm Swarm sarcoma (EHS) nidogen
were obtained from Chemicon Inc. (Temecula, CA, USA). Lami-
nin/nidogen complex purified from Engelbreth Holm Swarm
Sarcoma was kindly provided by Dr. Hynda Kleinman (National
Institutes of Health, Washington, D.C., USA).
Renal cortical meprin A purification
Rat renal cortical meprin A was purified from the renal cortices
of 100 male Sprague-Dawley rats as in our previous study [3].
Briefly, the renal cortices were homogenized in 50 mM Tris-HCl
buffer, pH 7.5 containing PMSF, leupeptin and pepstatin and the
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membrane fraction was obtained by ultracentrifugation at
100,000 3 g. The extracellular matrix degrading activity (using
[3H]-gelatin as substrate) was purified through a series of columns
including DE-52, hydroxylapatite, concanavalin A-sepharose, and
gelatin-sepharose. As in our previous study, this purified enzyme
preparation was homogeneous, gave a single band at 85 kDa on
SDS-PAGE under reducing conditions and was capable of de-
grading extracellular matrix components [3].
Nidogen purification from laminin-nidogen complex
Nidogen was isolated following the method of Paulsson et al [5].
Briefly, the laminin/nidogen complex (10 ml, ; 8 mg/ml; the kind
gift of Dr. Hynda Kleinman, National Institutes of Health) was
diluted to about 1 mg/ml, and dissociated by dialysing overnight
against 2 M guanidine-HCl, 50 mM Tris HCl (pH 7.4), 2 mM
EDTA, 0.5 mM PMSF, and 0.5 mM NEM at 4°C. The dissociated
complex was layered on a Sepharose CL-4B (2.5 3 100 cm)
column equilibrated with the guanidine-HCl buffer. Fractions
containing nidogen were pooled, concentrated to 1 mg/ml, and
dialysed against 0.1 M Tris (pH 7.5) and stored at 220°C.
Laminin/nidogen degradation
EHS laminin/nidogen complex (20 mg) and renal cortical
meprin A (1 mg) in 50 mM TriszHCl, pH 7.5 (final volume, 100 ml)
were incubated for various times at 37°C with shaking. In separate
experiments, purified nidogen (25 mg) or EHS sarcoma laminin/
nidogen complex (25 mg) and renal cortical meprin A (8 mg) were
incubated for 5H at 37°C with shaking. The samples were
examined using SDS-PAGE and immunoblotting.
Polyacrylamide gel electrophoresis and Western blotting
SDS-PAGE was carried out according to the method of Lae-
mmli [6] in 8% or 4 to 12% gradient gels. Immunoblotting was
carried out as in our previous study [3], Briefly, the proteins were
transferred to nitrocellulose membranes (Novex, San Diego, CA,
USA), blocked for one hour with non-fat milk and rinsed three
times for five minutes in PBS 1% Tween-20 buffer. The mem-
brane was then incubated shaking with anti-nidogen antibody at
1:10,000 dilution for one hour at room temperature. It was then
washed as above and incubated shaking with anti-mouse second-
ary antibody at 1:20,000 dilution for one hour at room tempera-
ture. The membrane was then washed as above followed by three
rinses, for five minutes each, with PBS-0.3% Tween-20. The blots
were detected using the ECL kit (Amersham Ltd., Arlington
Fig. 1. SDS-PAGE gel of laminin/nidogen complex incubated with me-
prin. Lane 1, molecular weight markers; Lane 2, laminin/nidogen alone,
16 hours; Lane 3, meprin plus laminin/nidogen complex for eight hours;
Lane 4, meprin plus laminin/nidogen complex for 16 hours; Lane 5,
molecular weight markers. A and B correspond to the light and heavy
chains of laminin, and the arrows show the fragments at 68, 55 and 47 kDa.
Fig. 2. SDS-PAGE gel of (lane 1) laminin/nidogen complex1 meprin, 0
hours; (lane 2) one hour; (lane 3) two hours; (lane 4) five hours; (lane 5)
eight hours; (lane 6) 18 hours; (lane 7) laminin/nidogen complex alone
five hours; (lane 8) laminin/nidogen complex 1 meprin 1 1,10 phenan-
throline, five hours; (lane 9) laminin/nidogen complex alone 18 hours; 10
molecular weight standards (200, 116, 97, 66, 55, 36, 31, and 21 kDa,
respectively).
Fig. 3. A. Genebank comparison of 55 kDa fragment with known se-
quences shows 100% homology with mouse nidogen. No other matches
were found. D 5 cleavage site (gln-gly). (B.) Location of the unique
meprin cleavage site of nidogen.
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Heights, IL, USA) per kit instructions. The blots were then
exposed to Hyperfilm-ECL x-ray film (Amersham Ltd.) for 10 to
60 seconds.
Amino acid sequence determination
Following incubation of meprin A with the laminin-nidogen
complex, the incubation mixture was subjected to SDS-PAGE and
then electrophoretically transferred to Immobilon P. The Immo-
bilon P membrane was then stained with Ponceau S to detect the
proteins and the 55 kDa band was excised, thoroughly washed
with water and submitted for peptide sequence analysis. The
amino terminal sequence analysis was performed by Harvard
Microchem (Boston, MA, USA) using an ABI 477A Protein
Sequencer with a 120A Online PTH-AA Analyzer.
Ischemia-reperfusion model
Renal ischemia-reperfusion injury was carried out essentially as
in our previous study [4]. Male Sprague-Dawley rats (240 to 300 g)
were housed in a federally approved vivarium in accordance with
NIH guidelines. The rats were rested from travel for at least five
days prior to experimentation with free access to standard rat
chow and water. The rat quarters were kept at a constant room
temperature with standard 12-hour day/night cycles. Forty-eight
hours prior to surgery, individual rats were placed in metabolic
cages. The metabolic cages were fitted with an ice-cooled urine
collection system. Twenty-four hours prior to surgery, urine
collection was begun and every 24 hours thereafter the urine was
removed, the total urine volume recorded and an aliquot frozen
for future analysis. Anesthetized rats underwent bilateral flank
incisions followed by isolation and occlusion of both renal pedicles
for 45 minutes under sterile conditions. After clamp release, the
incisions were closed and the animals returned to their metabolic
cages. Control animals underwent anesthesia, isolation of the
Fig. 4. Immunoblot reacted with monoclonal anti-mouse nidogen. The
lanes are: (1) laminin/nidogen complex 1 meprin, zero hours; (2) one
hour; (3) two hours; (4) five hours; (5) eight hours; (6) 18 hours; (7)
laminin/nidogen complex alone, five hours; (8) laminin/nidogen complex
1 meprin 1 1,10 phenanthroline, five hours; (9) laminin/nidogen complex
alone, 18 hours. (A) nidogen; (B) 68 kDa fragment; (C) 55 kDa fragment;
(D) 5 47 kDa fragment.
Fig. 5. Purification and isolation of nidogen from laminin/nidogen com-
plex. Column chromatography of previously dissociated laminin/nidogen
complex on Sepharose Cl-4B. Protein was determined by absorbance at
280 nm. Nidogen was detected by immunoblot and expressed as relative
units.
Table 1. Peptide bonds of nidogen cleaved by various proteases
Nidogen domain Peptide bond (position) Protease
G1 E-L (5–6) EG
E-L (34–35) EG
D-L (82–83) S
N-V (91–92) S
Link K-S (203–204) T, P
N-L (220–221) M
K-S (223–224) T
E-L (236–237) EG
K-G (244–245) T
G-L (275–276) M
R-I (300–301) T, Th
R-S (321–322) P, K, Th, T
R-F (329–330) T
E-T (345–346) EG
V-V (348–349) LE
F-S (350–351) Ch
S-Y (351–352) S
G3 P-I (896–897) S
E-R (925–926) EG
R-L (926–927) T
E-A (926–927) EG
I-I (950–951) LE
I-G (951–952) LE
R-A (974–975) T, Th
S-L (976–977) S, M
T-I (984–985) S
G-I (995–996) M
R-T (1003–1004) T
R-I (1016–1017) T
E-V (1018–1019) EG
A-K (1019–1020) LE
K-M (1020–1021) M
R-V (1026–1027) T
V-L (1027–1028) LE
R-G (1037–1038) Th
G-I (1038–1039) S
K-I (1059–1060) T
E-T (1061–1062) EG
S-H (1063–1064) LE
R-I (1071–1072) T
G-L (1083–1084) M
D-A (1087–1088) EG
R-A (1102–1103) T
E-C (1104–1105) EG
K-T (1139–1140) T
S-V (1142–1143) S
K-E (1152–1153) T
E-M (1153–1154) EG
The proteases examined were chymase (Ch), endoproteinase Glu-C
(EG), kallikrein (K), leukocyte elastase (LE), matrilysin (M), plasmin (P),
stromelysin (S), thrombin (Th), trypsin (T). The cleavage sites were
identified using the cDNA-derived sequence of mouse nidogen [8]. Table
modified after Mayer et al [13].
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renal pedicles and surgical exposure for 45 minutes without renal
pedicle occlusion. In a separate experiment, following 45 minutes
renal pedicle occlusion, rats were sacrificed after 3, 6, 18 and 24
hours and three and seven days using pentobarbitol sodium (50
mg/kg i.p.) and plasma was obtained for measurement of creati-
nine and urea nitrogen followed by exsanguination. In separate
studies to further detail the redistribution of meprin, control rats
and rats exposed to ischemia reperfusion injury as above were
divided into the following groups (N 5 3 for each group): control
group; 40 minutes ischemia alone; 40 minutes ischemia plus three
hours reperfusion; 40 minutes ischemia plus six hours reperfusion;
40 minutes ischemia plus 18 hours reperfusion; 40 minutes
ischemia plus two days reperfusion; 40 minutes ischemia plus
three days reperfusion; 40 minutes ischemia plus five days reper-
fusion; 40 minutes ischemia plus seven days reperfusion. Plasma
was obtained for measurement of creatinine and urea nitrogen
followed by exsanguination and the kidneys were obtained for
immunofluorescence examination.
Immunohistochemical procedures
The kidneys were bisected, thinly sliced, fixed in commercial
buffered formalin for four hours, dehydrated and embedded in
paraffin. The blocks were sectioned at 3 mm and mounted on
slides previously coated with poly L-lysine. The sections were
rinsed with PBS for 20 minutes and then reacted with polyclonal
rabbit anti-meprin A antibody [3] for one hour. The preparation
and characterization of the anti-meprin A antibody has been
described in detail in our previous report [3]. The sections were
then washed in three changes of phosphate buffered saline (PBS),
five minutes each, flooded with fluorescein conjugated goat
anti-rabbit IgG for one hour, washed again in three changes of
PBS, five minutes each and coverslipped with Aquamount
(Biomeda Corp, Foster City, CA, USA). Controls included re-
placement of specific antibodies with non-immune rabbit serum
or elimination of the primary antibody step. The sections were
examined using an Olympus BH-2 microscope with an epifluores-
cence attachment and photographed using an Olympus PM-10AD
photomicrographic system.
RESULTS
Laminin degradation by renal cortical meprin A
We examined the ability of meprin A to degrade laminin-
nidogen complex. Laminin-nidogen complex was incubated with
purified renal cortical meprin A for various times and the
hydrolyzed products were examined using SDS-PAGE. Renal
cortical meprin A produced a marked degradation of both the
light and heavy chains of laminin and fragments of 68-, 55-, and
47-kDa were observed on SDS-PAGE gels (Fig. 1). The cleavage
of laminin-nidogen complex was time dependent with the 68 and
55 kDa fragment appearing as early as one hour after the start of
the incubation (Fig. 2). Among these fragments, the 55 kDa
fragment was the most prominent throughout the time course.
Incubation of laminin-nidogen complex alone or laminin-nidogen
complex and meprin A with 1,10 phenanthroline, an inhibitor of
meprin A, resulted in essentially no degradation (Fig. 2).
Sequence determination
The N-terminal amino acid sequence of the 55 kDa product
obtained from an 18 hours incubation of meprin A with the
laminin-nidogen complex was determined. Unexpectedly, the
amino acid sequence was found to be 100% homologous to the
previously reported mouse sequence for nidogen (Fig. 3A) [7–13].
Comparison of the sequence to the Gene Bank revealed no
homology to laminin or to any other protein. This indicates that
the 55 kDa fragment is a cleavage product of the nidogen
component of the laminin-nidogen complex.
Examination of the cleavage site
The meprin A cleavage site is at position 899 to 900, a
glutamine-glycine (gln-gly) site in the nidogen molecule. Compar-
ison of the 55 kDa fragment cleavage site with over 50 nidogen
cleavage sites produced by granule stored proteases, blood pro-
teases, matrix metalloproteinases and trypsin revealed that the
meprin A-induced nidogen cleavage site (gln-gly) is unique (Table
1) [13, 14]. This unique nidogen fragment contains the laminin
binding site in the G-3 region (Fig. 3B) [13]. Given that no other
protease has been shown to cleave nidogen at this site, this site
and the 55 kDa fragment appear to be meprin specific and can
serve as a marker for meprin activity against nidogen.
Western blot
Since the sequence data revealed that the 55 kDa fragment was
a breakdown product of nidogen rather than laminin, we carried
out additional studies utilizing a monoclonal antibody specifically
directed against nidogen. EHS laminin-nidogen complex was
incubated for various times with and without renal cortical meprin
A. In addition, the metalloproteinase inhibitor 1 to 10 phenanth-
roline (2 mM) was added to one of the samples containing meprin
A and laminin-nidogen complex and incubated for 18 hours.
Immunoblotting with monoclonal anti-EHS nidogen revealed
both the 55 kDa fragment as well as a larger 68 kDa fragment and
a smaller 47 kDa fragment (Fig. 4). Western blot examination
using polyclonal anti-laminin antibodies revealed a marked de-
crease in the high molecular weight laminin subunits and faint
staining of the bands in the same position as those which were
markedly positive with anti-nidogen antibody (data not shown).
Given that the polyclonal antibodies were raised against EHS-
laminin without extraction of the integral nidogen, the faintly
Fig. 6. Purified nidogen was incubated with purified meprin A. Immu-
noblot reacted with monoclonal anti-mouse nidogen. The lanes are: (1)
isolated nidogen alone; (2) meprin 1 isolated nidogen, five hours; (3)
meprin 1 laminin-nidogen complex, five hours. Molecular mass is indi-
cated on the left border (kDa).
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Fig. 7. Immunofluorescence examination of meprin distribution in kidney following ischemia reperfusion injury. (A.) Uninjured control rats showing
fine brush border staining limited to the tubules in the corticomedullary junction. (B.) Immediately following 40 minutes of hypoxia and with no
reperfusion, there is a marked increase in brush border fluorescence intensity. (C.) Three hours following ischemia-reperfusion injury there is
redistribution of the the meprin staining to a supranuclear pattern with intense staining of renal tubular cytoplasm and extension to the basal area in
some cells. (D.) Six hours of reperfusion produces sloughing of epithelial cells, cell death and extensive cytoplasmic staining for meprin. Meprin is clearly
seen adherent to the underly basement membrane. There is also dense luminal staining in the medullary areas (part 2). (E) At 18 hours of reperfusion,
many of the lumens are obstructed by brightly meprin staining epithelial cells. Again, meprin is clearly evident at the tubular basement membrane. (F.)
Two days following ischemia-reperfusion injury, there is pronounced luminal obstruction by meprin containing cells and continued tubular basement
membrane meprin staining. (G.) On day 3, there is an apparent reduction in residual intact cellular meprin staining with continued prominent luminal
obstruction by meprin staining cells. (H.) By day 5, the luminal obstruction had decreased and brush border meprin stain was returning. (I.) On day 7,
the meprin staining had more the appearance of the control animals, though some luminal obstruction by meprin staining tubular epithelial cells
remained in rare areas. (J.) Elevation of plasma creatinine and urea nitrogen following ischemia reperfusion injury.
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Figure 7. Continued.
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positive staining is presumably due to an anti-nidogen component
within the polyclonal antibody.
Meprin A degradation of purified nidogen
Nidogen was extracted from EHS laminin-nidogen complex and
separated by column chromatography on a Sepharose CL-4B
column. Nidogen appeared in the second protein peak (Fig. 5) as
previously described [5]. Incubation of purified nidogen with meprin
A for five hours resulted in marked nidogen fragmentation with
major bands at 80, 68 and 55 kDa as shown by Western blot (Fig. 6).
These fragments were also present following incubation of meprin A
with laminin-nidogen complex for five hours (Fig. 6).
Ischemia-reperfusion injury model
Immunofluorescence examination of the kidneys (Fig. 7) re-
vealed fine brush border staining of the tubules in the cortico-
medullary junction. This staining pattern was similar to the renal
tubular localization of meprin reported previously by Craig,
Reckelhoff and Bond [15].
Following 40 minutes of ischemia, there was a marked increase
in fluorescence intensity for meprin in the brush border (Fig. 7).
Within three hours there was a shift of meprin from the brush
border to the supranuclear area and the general cytoplasm. By six
hours there was generalized cytoplasmic staining for meprin,
luminal meprin and meprin adherent to the basement membrane.
These features intensified over the next hours and days, demon-
strating continued cytoplasmic intraluminal and extracellular ma-
trix localization (Fig. 7). Cell sloughing and tubular obstruction
with intense meprin staining was also observed. Luminal meprin
could be seen throughout the tubule length, extending into the
medulla and into distal tubule lumens. By day 5, there was
evidence of some return to normal localization, which was some-
what more developed by day 7 (Fig. 7). These changes paralleled
the alterations seen in renal function. The plasma urea nitrogen
and creatinine rose rapidly, peaking at 24 hours (creatinine 2.9 6
0.2; urea nitrogen 98 6 4 mg/dl, at 24 hr; N 5 3; Fig. 7).
Twenty-four-hour urine collections were carried out on rats
which had undergone bilateral renal ischemia-reperfusion injury.
Western blotting with anti-nidogen antibody revealed a faint 55
kDa nidogen fragment in the control urine which was significantly
increased on day 1 and was markedly increased on days 4 and 5
(Fig. 8). This 55 kDa fragment persisted through day 6, returning
to near baseline levels on day 7. A 31 kDa fragment was also
present in control urine. This fragment was decreased slightly on
day 1, markedly increased through day 6 and approached baseline
by day 7. A much lower intensity 36 kDa fragment appeared on
day 2, peaking at day 5 and no longer visible at day 7. Renal
function studies were similar to those shown above with creatinine
peaking at 24 hours and plasma urea nitrogen at 18 hours (data
not shown).
In preliminary studies, we attempted to sequence the urine 55
kDa fragment. However, there was cross contamination with a
variety of other proteins yielding no specific sequence informa-
tion. Nonetheless, the Western blot using a highly specific mono-
clonal anti-nidogen antibody, unequivocally demonstrates the
presence of the 55 kDa nidogen breakdown product.
DISCUSSION
The first aim of this study was to examine the ability of meprin
A to degrade the laminin-nidogen complex and to identify the
major breakdown products. N-terminal sequence information
from the most abundant 55 kDa fragment revealed that it was a
breakdown product of nidogen rather than laminin as we had
initially anticipated. Western blot analysis with monoclonal anti-
nidogen antibody demonstrated a markedly positive band at 55
kDa as well as several other bands. Meprin A degraded intact
nidogen purified from the laminin-nidogen complex into similar
nidogen fragments.
Nidogen is very sensitive to protease degradation and a number
of proteolytic enzymes have been shown to be active against
nidogen [13, 14]. However, the ability of meprin A, the major
matrix degrading enzyme in renal tubules [3], to degrade nidogen
has not been previously demonstrated. The meprin A induced
cleavage site gln-gly at 899 to 900 is also unique. This meprin
A-nidogen cleavage site occurs in the G-3 domain, which is one of
the most vulnerable sites for proteolytic degradation of isolated
nidogen [13]. However, this domain contains the laminin binding
site and the G3 domain of nidogen is usually protected against
proteolytic degradation when combined with laminin [13]. Yet our
data demonstrate that meprin A degrades the G3 domain of
nidogen even in the presence of laminin binding.
Given that the tubular basement membrane is located on the
Fig. 8. Immunoblot detection of nidogen in daily 24-hour urine collec-
tions following ischemia-reperfusion injury. (A.) The immunoblots were
scanned and analyzed with a densitometer. The mean 1 SEM of three rats
is shown. (B.) Representative immunoblot. The lanes are: (0) control; (1)
day 1; (2) day 2; (3) day 3; (4) day 4; (5) day 5; (6) day 6; (7) day 7.
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basilar side of the cell, the location of meprin A on the apical
brush border makes it difficult to envision a role for meprin A in
injury-induced basement membrane component breakdown.
Thus, we examined the possibility that following renal tubular
epithelial cell injury, meprin A undergoes a translocation to reach
the underlying basement membrane. After renal ischemia-reper-
fusion, there was a marked alteration in meprin A staining with
meprin A now distributed throughout the renal tubular cell
cytoplasm and directly adherent to the tubular basement mem-
brane. This was in contrast to the usual linear staining of the brush
border of tubules in the corticomedullary junction. These data
provide unequivocal evidence that following injury, meprin A
undergoes redistribution from the brush border to the cytoplasm
and is found adherent to the tubular basement membrane.
Since in our in vitro studies, we identified a distinct meprin-
induced 55 kDa nidogen breakdown product, the urine was also
examined for the presence of nidogen degradation products after
rat renal ischemia-reperfusion injury. Western blots showed a
marked increase in the urinary 55 kDa nidogen fragment as early
as the first day following ischemia-reperfusion injury and continu-
ing for six days. Taken together, these in vivo data strongly
support the notion that the nidogen breakdown products are the
result of partial degradation of tubular basement membrane by
meprin A following renal tubular ischemia-reperfusion injury.
Combined with our previous report showing alterations in renal
tubular basement membrane components following ischemia-
reperfusion injury [4], the current study suggests that meprin A
plays an important pathophysiologic role in ischemia-reperfusion
induced acute renal failure. Nidogen is an important component
of basement membrane and co-localizes with laminin [reviewed in
16]. The structure of nidogen has been determined and it contains
both a type IV collagen and a laminin binding domain. Since
laminin does not contain a binding site for type IV collagen, it is
quite possible that nidogen provides an “adhesive bridge” be-
tween laminin and type IV collagen [11]. Disruption of this
attachment factor could lead to loss of laminin from the tubular
basement membrane. Nidogen also contains at least two potential
calcium binding sequences: epidermal growth factor homologous
repeats, and an RGD integrin recognition sequence [17, 18].
Nidogen plays a crucial role in basement membrane formation,
stabilization and organization [19]. It has also been shown to play
an important role in cell adhesion [20] and in basement mem-
brane formation during embryogenesis [reviewed in 21]. Given its
overall importance to basement membrane structure and func-
tion, fragmentation and/or loss of nidogen would likely have
significant detrimental consequences. Indeed, in a recent report,
Trachtman et al demonstrated that mice strains with low levels of
renal tubular meprin A have less ischemia induced renal failure
than mice strains with normal levels of meprin A [22].
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